Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00285142
Status:
COMPLETED
Last Update Posted:
2019-06-10
First Post:
2006-01-31
Brief Title:
Effect of Rosiglitazone
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Assessment of the Effect of Rosiglitazone on Insulin Secretion in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2006-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate
acute effects of a single dose of 8 mg rosiglitazone therapeutic dose
on insulin secretion and
insulin sensitivity in 12 healthy male subjects
acute effects of a single dose of 8 mg rosiglitazone therapeutic dose
on insulin secretion and
insulin sensitivity in 12 healthy male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None